▶ 調査レポート

女性健康診断の世界市場(~2026年)

• 英文タイトル:Global Women Health Diagnostics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。女性健康診断の世界市場(~2026年) / Global Women Health Diagnostics Market Size, Status and Forecast 2020-2026 / MRC2-11QY05114資料のイメージです。• レポートコード:MRC2-11QY05114
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は女性健康診断のグローバル市場について調査・分析したレポートです。種類別(乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニングおよび保菌検査、超音波検査、HIV検査)市場規模、用途別(診断および画像センター、病院および診療所、在宅ケア)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別女性健康診断の競争状況、市場シェア
・世界の女性健康診断市場:種類別市場規模 2015年-2020年(乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニングおよび保菌検査、超音波検査、HIV検査)
・世界の女性健康診断市場:種類別市場規模予測 2021年-2026年(乳がん検査、子宮頸がん検査、骨粗鬆症検査、妊娠検査、受精能検査、卵巣がん検査、感染症検査、出生前遺伝子スクリーニングおよび保菌検査、超音波検査、HIV検査)
・世界の女性健康診断市場:用途別市場規模 2015年-2020年(診断および画像センター、病院および診療所、在宅ケア)
・世界の女性健康診断市場:用途別市場規模予測 2021年-2026年(診断および画像センター、病院および診療所、在宅ケア)
・北米の女性健康診断市場分析:米国、カナダ
・ヨーロッパの女性健康診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの女性健康診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の女性健康診断市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの女性健康診断市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Quest Diagnostics、Abbott、BD、Roche、GE Healthcare、Biomérieux、Philips、DIALAB、Fujifilm、GenMark、Hologic、Luminex、Nova Biomedical、PerkinElmer、Siemens Healthineers
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Women’s experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.
Rising prevalence of infectious diseases in women coupled with the increasing incidences of the chronic & lifestyle disorders are the key factors driving the global women health diagnostics market.

Market Analysis and Insights: Global Women Health Diagnostics Market
The global Women Health Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Women Health Diagnostics Scope and Market Size
Women Health Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Women Health Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Quest Diagnostics
Abbott
BD
Roche
GE Healthcare
Biomérieux
Philips
DIALAB
Fujifilm
GenMark
Hologic
Luminex
Nova Biomedical
PerkinElmer
Siemens Healthineers

Market segment by Type, the product can be split into
Breast cancer testing
Cervical cancer testing
Osteoporosis testing
Pregnancy & fertility testing
Ovarian cancer testing
Infectious disease testing
Prenatal genetic screening and carrier testing
Ultrasound tests
HIV testing
Market segment by Application, split into
Diagnostic and imaging centers
Hospitals and clinics
Home care

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Women Health Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Women Health Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Breast cancer testing
1.4.3 Cervical cancer testing
1.4.4 Osteoporosis testing
1.4.5 Pregnancy & fertility testing
1.4.6 Ovarian cancer testing
1.4.7 Infectious disease testing
1.4.8 Prenatal genetic screening and carrier testing
1.4.9 Ultrasound tests
1.4.10 HIV testing
1.5 Market by Application
1.5.1 Global Women Health Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic and imaging centers
1.5.3 Hospitals and clinics
1.5.4 Home care
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Women Health Diagnostics Market Perspective (2015-2026)
2.2 Global Women Health Diagnostics Growth Trends by Regions
2.2.1 Women Health Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Women Health Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Women Health Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Women Health Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Women Health Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Women Health Diagnostics Players by Market Size
3.1.1 Global Top Women Health Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Women Health Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Women Health Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Women Health Diagnostics Market Concentration Ratio
3.2.1 Global Women Health Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Women Health Diagnostics Revenue in 2019
3.3 Women Health Diagnostics Key Players Head office and Area Served
3.4 Key Players Women Health Diagnostics Product Solution and Service
3.5 Date of Enter into Women Health Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Women Health Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Women Health Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Women Health Diagnostics Market Size by Application (2015-2020)
5.2 Global Women Health Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Women Health Diagnostics Market Size (2015-2020)
6.2 Women Health Diagnostics Key Players in North America (2019-2020)
6.3 North America Women Health Diagnostics Market Size by Type (2015-2020)
6.4 North America Women Health Diagnostics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Women Health Diagnostics Market Size (2015-2020)
7.2 Women Health Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Women Health Diagnostics Market Size by Type (2015-2020)
7.4 Europe Women Health Diagnostics Market Size by Application (2015-2020)

8 China
8.1 China Women Health Diagnostics Market Size (2015-2020)
8.2 Women Health Diagnostics Key Players in China (2019-2020)
8.3 China Women Health Diagnostics Market Size by Type (2015-2020)
8.4 China Women Health Diagnostics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Women Health Diagnostics Market Size (2015-2020)
9.2 Women Health Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Women Health Diagnostics Market Size by Type (2015-2020)
9.4 Japan Women Health Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Women Health Diagnostics Market Size (2015-2020)
10.2 Women Health Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Women Health Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Women Health Diagnostics Market Size by Application (2015-2020)

11 India
11.1 India Women Health Diagnostics Market Size (2015-2020)
11.2 Women Health Diagnostics Key Players in India (2019-2020)
11.3 India Women Health Diagnostics Market Size by Type (2015-2020)
11.4 India Women Health Diagnostics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Women Health Diagnostics Market Size (2015-2020)
12.2 Women Health Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Women Health Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Women Health Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Quest Diagnostics
13.1.1 Quest Diagnostics Company Details
13.1.2 Quest Diagnostics Business Overview
13.1.3 Quest Diagnostics Women Health Diagnostics Introduction
13.1.4 Quest Diagnostics Revenue in Women Health Diagnostics Business (2015-2020))
13.1.5 Quest Diagnostics Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Women Health Diagnostics Introduction
13.2.4 Abbott Revenue in Women Health Diagnostics Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 BD
13.3.1 BD Company Details
13.3.2 BD Business Overview
13.3.3 BD Women Health Diagnostics Introduction
13.3.4 BD Revenue in Women Health Diagnostics Business (2015-2020)
13.3.5 BD Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Women Health Diagnostics Introduction
13.4.4 Roche Revenue in Women Health Diagnostics Business (2015-2020)
13.4.5 Roche Recent Development
13.5 GE Healthcare
13.5.1 GE Healthcare Company Details
13.5.2 GE Healthcare Business Overview
13.5.3 GE Healthcare Women Health Diagnostics Introduction
13.5.4 GE Healthcare Revenue in Women Health Diagnostics Business (2015-2020)
13.5.5 GE Healthcare Recent Development
13.6 Biomérieux
13.6.1 Biomérieux Company Details
13.6.2 Biomérieux Business Overview
13.6.3 Biomérieux Women Health Diagnostics Introduction
13.6.4 Biomérieux Revenue in Women Health Diagnostics Business (2015-2020)
13.6.5 Biomérieux Recent Development
13.7 Philips
13.7.1 Philips Company Details
13.7.2 Philips Business Overview
13.7.3 Philips Women Health Diagnostics Introduction
13.7.4 Philips Revenue in Women Health Diagnostics Business (2015-2020)
13.7.5 Philips Recent Development
13.8 DIALAB
13.8.1 DIALAB Company Details
13.8.2 DIALAB Business Overview
13.8.3 DIALAB Women Health Diagnostics Introduction
13.8.4 DIALAB Revenue in Women Health Diagnostics Business (2015-2020)
13.8.5 DIALAB Recent Development
13.9 Fujifilm
13.9.1 Fujifilm Company Details
13.9.2 Fujifilm Business Overview
13.9.3 Fujifilm Women Health Diagnostics Introduction
13.9.4 Fujifilm Revenue in Women Health Diagnostics Business (2015-2020)
13.9.5 Fujifilm Recent Development
13.10 GenMark
13.10.1 GenMark Company Details
13.10.2 GenMark Business Overview
13.10.3 GenMark Women Health Diagnostics Introduction
13.10.4 GenMark Revenue in Women Health Diagnostics Business (2015-2020)
13.10.5 GenMark Recent Development
13.11 Hologic
10.11.1 Hologic Company Details
10.11.2 Hologic Business Overview
10.11.3 Hologic Women Health Diagnostics Introduction
10.11.4 Hologic Revenue in Women Health Diagnostics Business (2015-2020)
10.11.5 Hologic Recent Development
13.12 Luminex
10.12.1 Luminex Company Details
10.12.2 Luminex Business Overview
10.12.3 Luminex Women Health Diagnostics Introduction
10.12.4 Luminex Revenue in Women Health Diagnostics Business (2015-2020)
10.12.5 Luminex Recent Development
13.13 Nova Biomedical
10.13.1 Nova Biomedical Company Details
10.13.2 Nova Biomedical Business Overview
10.13.3 Nova Biomedical Women Health Diagnostics Introduction
10.13.4 Nova Biomedical Revenue in Women Health Diagnostics Business (2015-2020)
10.13.5 Nova Biomedical Recent Development
13.14 PerkinElmer
10.14.1 PerkinElmer Company Details
10.14.2 PerkinElmer Business Overview
10.14.3 PerkinElmer Women Health Diagnostics Introduction
10.14.4 PerkinElmer Revenue in Women Health Diagnostics Business (2015-2020)
10.14.5 PerkinElmer Recent Development
13.15 Siemens Healthineers
10.15.1 Siemens Healthineers Company Details
10.15.2 Siemens Healthineers Business Overview
10.15.3 Siemens Healthineers Women Health Diagnostics Introduction
10.15.4 Siemens Healthineers Revenue in Women Health Diagnostics Business (2015-2020)
10.15.5 Siemens Healthineers Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Women Health Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Women Health Diagnostics Revenue
Table 3. Ranking of Global Top Women Health Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Women Health Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Breast cancer testing
Table 6. Key Players of Cervical cancer testing
Table 7. Key Players of Osteoporosis testing
Table 8. Key Players of Pregnancy & fertility testing
Table 9. Key Players of Ovarian cancer testing
Table 10. Key Players of Infectious disease testing
Table 11. Key Players of Prenatal genetic screening and carrier testing
Table 12. Key Players of Ultrasound tests
Table 13. Key Players of HIV testing
Table 14. Global Women Health Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Women Health Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Women Health Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Women Health Diagnostics Market Share by Regions (2015-2020)
Table 18. Global Women Health Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Women Health Diagnostics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Women Health Diagnostics Market Growth Strategy
Table 24. Main Points Interviewed from Key Women Health Diagnostics Players
Table 25. Global Women Health Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Women Health Diagnostics Market Share by Players (2015-2020)
Table 27. Global Top Women Health Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Diagnostics as of 2019)
Table 28. Global Women Health Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Women Health Diagnostics Product Solution and Service
Table 31. Date of Enter into Women Health Diagnostics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Women Health Diagnostics Market Size Share by Type (2015-2020)
Table 35. Global Women Health Diagnostics Revenue Market Share by Type (2021-2026)
Table 36. Global Women Health Diagnostics Market Size Share by Application (2015-2020)
Table 37. Global Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Women Health Diagnostics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Women Health Diagnostics Market Share (2019-2020)
Table 41. North America Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Women Health Diagnostics Market Share by Type (2015-2020)
Table 43. North America Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Women Health Diagnostics Market Share by Application (2015-2020)
Table 45. Europe Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Women Health Diagnostics Market Share (2019-2020)
Table 47. Europe Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Women Health Diagnostics Market Share by Type (2015-2020)
Table 49. Europe Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Women Health Diagnostics Market Share by Application (2015-2020)
Table 51. China Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Women Health Diagnostics Market Share (2019-2020)
Table 53. China Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 54. China Women Health Diagnostics Market Share by Type (2015-2020)
Table 55. China Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 56. China Women Health Diagnostics Market Share by Application (2015-2020)
Table 57. Japan Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Women Health Diagnostics Market Share (2019-2020)
Table 59. Japan Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Women Health Diagnostics Market Share by Type (2015-2020)
Table 61. Japan Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Women Health Diagnostics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Women Health Diagnostics Market Share (2019-2020)
Table 65. Southeast Asia Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Women Health Diagnostics Market Share by Type (2015-2020)
Table 67. Southeast Asia Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Women Health Diagnostics Market Share by Application (2015-2020)
Table 69. India Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Women Health Diagnostics Market Share (2019-2020)
Table 71. India Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 72. India Women Health Diagnostics Market Share by Type (2015-2020)
Table 73. India Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 74. India Women Health Diagnostics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Women Health Diagnostics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Women Health Diagnostics Market Share (2019-2020)
Table 77. Central & South America Women Health Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Women Health Diagnostics Market Share by Type (2015-2020)
Table 79. Central & South America Women Health Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Women Health Diagnostics Market Share by Application (2015-2020)
Table 81. Quest Diagnostics Company Details
Table 82. Quest Diagnostics Business Overview
Table 83. Quest Diagnostics Product
Table 84. Quest Diagnostics Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 85. Quest Diagnostics Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Product
Table 89. Abbott Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 90. Abbott Recent Development
Table 91. BD Company Details
Table 92. BD Business Overview
Table 93. BD Product
Table 94. BD Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 95. BD Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. GE Healthcare Company Details
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Product
Table 104. GE Healthcare Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 105. GE Healthcare Recent Development
Table 106. Biomérieux Company Details
Table 107. Biomérieux Business Overview
Table 108. Biomérieux Product
Table 109. Biomérieux Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 110. Biomérieux Recent Development
Table 111. Philips Company Details
Table 112. Philips Business Overview
Table 113. Philips Product
Table 114. Philips Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 115. Philips Recent Development
Table 116. DIALAB Business Overview
Table 117. DIALAB Product
Table 118. DIALAB Company Details
Table 119. DIALAB Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 120. DIALAB Recent Development
Table 121. Fujifilm Company Details
Table 122. Fujifilm Business Overview
Table 123. Fujifilm Product
Table 124. Fujifilm Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 125. Fujifilm Recent Development
Table 126. GenMark Company Details
Table 127. GenMark Business Overview
Table 128. GenMark Product
Table 129. GenMark Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 130. GenMark Recent Development
Table 131. Hologic Company Details
Table 132. Hologic Business Overview
Table 133. Hologic Product
Table 134. Hologic Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 135. Hologic Recent Development
Table 136. Luminex Company Details
Table 137. Luminex Business Overview
Table 138. Luminex Product
Table 139. Luminex Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 140. Luminex Recent Development
Table 141. Nova Biomedical Company Details
Table 142. Nova Biomedical Business Overview
Table 143. Nova Biomedical Product
Table 144. Nova Biomedical Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 145. Nova Biomedical Recent Development
Table 146. PerkinElmer Company Details
Table 147. PerkinElmer Business Overview
Table 148. PerkinElmer Product
Table 149. PerkinElmer Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 150. PerkinElmer Recent Development
Table 151. Siemens Healthineers Company Details
Table 152. Siemens Healthineers Business Overview
Table 153. Siemens Healthineers Product
Table 154. Siemens Healthineers Revenue in Women Health Diagnostics Business (2015-2020) (Million US$)
Table 155. Siemens Healthineers Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women Health Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Breast cancer testing Features
Figure 3. Cervical cancer testing Features
Figure 4. Osteoporosis testing Features
Figure 5. Pregnancy & fertility testing Features
Figure 6. Ovarian cancer testing Features
Figure 7. Infectious disease testing Features
Figure 8. Prenatal genetic screening and carrier testing Features
Figure 9. Ultrasound tests Features
Figure 10. HIV testing Features
Figure 11. Global Women Health Diagnostics Market Share by Application: 2020 VS 2026
Figure 12. Diagnostic and imaging centers Case Studies
Figure 13. Hospitals and clinics Case Studies
Figure 14. Home care Case Studies
Figure 15. Women Health Diagnostics Report Years Considered
Figure 16. Global Women Health Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Women Health Diagnostics Market Share by Regions: 2020 VS 2026
Figure 18. Global Women Health Diagnostics Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Women Health Diagnostics Market Share by Players in 2019
Figure 21. Global Top Women Health Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women Health Diagnostics as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Women Health Diagnostics Revenue in 2019
Figure 23. North America Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Women Health Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed